MedPath

Examining the Effect of a Digital Medical Device for Cognitive and Musical Training in Children With Reading Disabilities

Not Applicable
Completed
Conditions
Learning Disorders, Specific
Learning Disabilities
Specific Learning Disorder, With Impairment in Reading
Dyslexia
Interventions
Device: Poppins Clinical
Registration Number
NCT06596980
Lead Sponsor
Poppins
Brief Summary

The goal of this clinical trial is to assess the effect on reading skills of the digital medical device Poppins Clinical for cognitive and musical training in pediatric participants (ages 7-11) with a specific learning disability with reading deficit. The main objective of the study is to assess the evolution in reading skills through a word reading task before and after the intervention.

Participants will be asked to train with the digital medical device Poppins Clinical 5 times per week for 8 weeks.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
38
Inclusion Criteria
  • Diagnosis of SLD with reading deficit, based on a speech-language assessment. SLD with reading deficit is defined in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR, 2022) and the International Classification of Diseases (ICD-11, 2022). The speech-language assessment should consist of at least three reading and/or transcription tests with a SD (standard deviation) of at least - 1.4 or a result below the 20th percentile or two reading and/or transcription tests with a SD of at least - 2 SD or a results below the 10th percentile;
  • Subject aged between 7 and 11, enrolled from CE1 to CM2;
  • French mother tongue or French bilingualism at home and more than 3 years schooling in France;
  • Tablet or smartphone available at home;
  • Subject affiliated to the French National Insurance (Securite Sociale)
  • Subject and parental/legal guardians consent to participate, and commitment to follow the protocol.
Exclusion Criteria
  • Subject has previously used Poppins Clinical or Mila-Learn;
  • Uncontrolled chronic illness (at investigator's discretion);
  • Previous epileptic seizures;
  • Participant actively participating in an interventional study that may affect results.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Interventional armPoppins ClinicalUse of the medical device Poppins Clinical 5 times per weeks (20 minutes training sessions)
Primary Outcome Measures
NameTimeMethod
Effect of Poppins Clinical on reading abilities (accuracy)8 weeks

Evaluate the effect of 8 weeks of training with Poppins Clinical on reading abilities (in terms of reading accuracy) of participants using a word reading task and measuring the number of correctly read words.

Secondary Outcome Measures
NameTimeMethod
Reported adverse events8 weeks

To evaluate safety, reported adverse events during the 8 weeks follow-up phase will be evaluated.

Effect of Poppins Clinical on reading abilities (speed)8 weeks

Evaluate the effect of 8 weeks of training with Poppins Clinical on reading abilities (in terms of speed) of participants using a word reading task and measuring the number of read words.

Effect of Poppins Clinical on phonological skills8 weeks

Evaluate the effect of 8 weeks of training with Poppins Clinical on phonological skills of participants using the BALE test.

Comparison of the effect of Poppins Clinicals to a former version of the device on reading abilities (accuracy)8 weeks

Compare the effect of Poppins Clinical to the effect of the former version of the medical device (Mila-Learn) on reading abilities (in terms of reading accuracy) using a word reading task and measuring the number of correctly read words.

Comparison of the effect of Poppins Clinicals to a former version of the device on reading abilities (speed)8 weeks

Compare the effect of Poppins Clinical to the effect of the former version of the medical device (Mila-Learn) on reading abilities (in terms of reading speed) using a word reading task and measuring the number of read words.

Trial Locations

Locations (1)

Hôpital Pitié-Salpêtrière

🇫🇷

Paris, France

© Copyright 2025. All Rights Reserved by MedPath